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Abstract
Engineered metalloproteins constitute a flexible new class of analyte-sensitive molecular imaging
agents detectable by magnetic resonance imaging (MRI), but their contrast effects are generally
weaker than synthetic agents. To augment the proton relaxivity of agents derived from the heme
domain of cytochrome P450 BM3 (BM3h), we formed manganese(III)-containing proteins that
have higher electron spin than their native ferric iron counterparts. Metal substitution was
achieved by coexpressing BM3h variants with the bacterial heme transporter ChuA in Escherichia
coli and supplementing the growth medium with Mn3+-protoporphyrin IX. Manganic BM3h
variants exhibited up to 2.6-fold higher T1 relaxivities relative to native BM3h at 4.7 T.
Application of ChuA-mediated porphyrin substitution to a collection of thermostable chimeric
P450 domains resulted in a stable, high-relaxivity BM3h derivative displaying a 63% relaxivity
change upon binding of arachidonic acid, a natural ligand for the P450 enzyme and an important
component of biological signaling pathways. This work demonstrates that protein-based MRI
sensors with robust ligand sensitivity may be created with ease by including metal substitution
among the toolkit of methods available to the protein engineer.
To be useful in the laboratory or clinic, responsive MRI contrast agents for molecular
imaging must display large 1H NMR relaxivity changes at field strengths above 1 T.1,2 This
requirement presents a unique challenge for metalloprotein-based contrast agents, which are
limited by the natural magnetic and solvent interaction parameters of protein-coordinated
transition metals3,4 or biomineralized deposits.5 A class of engineered ligand-responsive
contrast agents recently generated by us through directed evolution of the heme domain of
Bacillus megaterium cytochrome P450 BM3 (BM3h)6 exemplifies this problem. Although
BM3h-based neurotransmitter sensors were shown to detect dopamine release in living rat
brains, the initial experiments were relatively insensitive because of the low longitudinal
(T1) relaxivity of these proteins (r1 ≈ 1 mM−1 s−1 at 22 °C and 4.7 T). BM3h derivatives
with improved relaxivity could offer better analyte sensitivity and reduced potential for
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ligand buffering in vivo while continuing to provide the advantages of a readily engineered
protein framework for tuning analyte binding properties.
Electron spin (S) is a critical factor governing the proton relaxivity of metal ion complexes.7
BM3h variants contain a porphyrin-bound ferric ion, which is thought to exist primarily in a
low-spin (S = ½) state. We therefore sought to increase the relaxivity of BM3h by replacing
the native heme with a protoporphyrin IX (PPIX) complex containing a higher-spin (S = 2)
Mn3+ ion.
Classical strategies for generating porphyrin-substituted heme proteins are based on often
cumbersome refolding protocols and are generally impractical on the moderate- to high-
throughput scale demanded by protein engineering applications. More recent approaches
require the use of specialized bacterial strains and can involve restrictive growth
conditions.8-10 We found that porphyrin-substituted BM3h variants could be expressed in
high yield under conventional culture conditions in a typical Escherichia coli BL21 strain by
coinducing expression of the gene of interest with the E. coli O157:H7 outer-membrane
heme transporter ChuA.11-13 Cells cotransformed with both BM3h- and ChuA-encoding
plasmids were grown in supplemented M9 minimal medium and induced in the presence of
Mn-PPIX (Figure 1A). Purified manganic protein yields of 20–30 mg/L of batch culture
were easily obtained.
Mn3+-substituted and native iron-containing proteins showed identical mobilities in
nondenaturing gel electrophoresis (Figure 1A inset) and identical circular dichroism spectra
(Figure 1B inset), suggesting that the manganic and native ferric species are similarly
folded. Purified manganic BM3h (Mn-BM3h) exhibited a broad Soret band with λmax = 386
nm, consistent with thiolate ligation of the manganic ion14 and distinct from both ferric
BM3h and free Mn-PPIX (Figure S1 in the Supporting Information). Despite functional
heme biosynthesis machinery in expression cells, inductively coupled plasma atomic
emission spectroscopy confirmed that >95% of the purified metalloprotein contained
manganese. To demonstrate the generality of the ChuA-based BM3h porphyrin substitution
technique for diverse potential applications, diamagnetic Co3+- and Zn2+-containing PPIX
species were also inserted in separate trials. Each gave rise to a species with a distinct UV-
vis absorbance spectrum (Figure 1B and Table S1 in the Supporting Information).
Mn-BM3h exhibited a T1 longitudinal relaxivity of 2.6 ± 0.1 mM−1 s−1 at 23 °C and 4.7 T, a
2-fold improvement over the native ferric BM3h r1 of 1.3 ± 0.1 mM−1 s−1 (Figure 2A). The
relaxivity of Mn-BM3h peaked at lower field, and the greatest absolute r1 difference
between the manganic and ferric proteins was observed at 1.0 T. The Mn-BM3h relaxivities
were also comparable to r1 values recorded at similar field strengths for other Mn-PPIX-
substituted refolded proteins.15 Despite the structural perturbation expected upon metal
substitution,16 Mn-BM3h was slightly more stable than native BM3h. The variants have
thermal denaturation midpoint temperature (T50) values of 54.6 and 51.9 °C, respectively, as
measured using 10 min incubation periods (Figure S2).17
To test the potential of Mn-BM3h to act as a ligand-dependent responsive contrast agent, we
examined its relaxivity change in the presence of arachidonic acid (AA), a natural ligand
shown to decrease r1 by 66% upon binding to native BM3h.6 While optical titration (Figure
S3) indicated that AA could bind to Mn-BM3h with a dissociation constant (Kd) of 0.7 ± 0.5
μM, we found that the r1 of wild-type Mn-BM3h changed by only 1.1% upon AA binding.
Proteins with improved basal relaxivity, stability, and ligand responsiveness were observed
from among a further set of Mn3+-substituted BM3h variants. The collection included a
recently reported variant engineered for dopamine sensing by MRI6 and five thermostable
chimeric P450 domains identified previously from a library of artificially recombined BM3h
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homologues17 (Table S2). Diverse combinations of r1 and T50 were observed among the
manganic variants (Figure 2B), indicating that both parameters can be tuned by mutagenesis
of the Mn-BM3h platform.
The Mn3+-containing proteins with the highest relaxivities and stabilities comparable to or
better than wild-type Mn-BM3h were titrated with AA to determine the corresponding Kd
values and relaxivity changes upon binding. A variant called Mn-C1634 displayed the best
combination of properties, with a relaxivity of 3.3 ± 0.2 mM−1 s−1, a T50 value of 56.0 ± 0.1
°C, and an AA dissociation constant of 2.5 ± 0.7 μM. AA binding resulted in a 63 ± 2.5%
decrease in r1 and could be visualized by optical absorbance changes or MRI (Figure 2C,D).
Mn-C1634 also exhibited modest T2 relaxivity (r2) averaging 7.4 ± 0.3 mM−1 s−1 over the
AA concentration range (Figure S4). Several potential competitors with structural similarity
to AA showed substantially less binding to Mn-C1634 (Figure S5). These optical and MRI
results indicate that Mn-C1634 could be useful for imaging-based detection of AA in tissue
culture or living organisms, where AA is a key component of inflammatory signaling and
reaches concentrations as high as 100 μM in some contexts.18
The AA-dependent relaxivity change from 3.3 to 1.2 mM−1 s−1 in Mn-C1634 is greater by a
factor of 2.4 than the Δr1 values exhibited by first-generation ferric BM3h-based MRI
sensors and also comparable to high-field relaxivity changes reported in the literature for
synthetic Gd3+-based responsive contrast agents.1 Through a combination of ChuA-
mediated metal substitution and traditional protein engineering techniques applied to BM3h,
it could be possible to access further gains in relaxivity as well as alterations of ligand
specificity and other properties. The present work demonstrates more generally that metal
substitution techniques can be an important component of efforts to engineer effective
protein-based sensors for molecular MRI.
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Figure 1.
Formation and characterization of purified metalloporphyrin-substituted cytochrome P450
BM3h proteins. (A) Schematic showing recombinant expression of metal-substituted BM3h
species in E. coli coexpressing BM3h (black) with the ChuA porphryin transporter (green),
supplemented with protoporphyrin IX (PPIX) complexes. The gel fragment in the inset at
the lower-right indicates equivalent mobilities of purified ferric and manganic BM3h in
nondenaturing 7.5% polyacrylamide gel electrophoresis; the colored bands arise from
natural pigmentation of the proteins. (B) Absorbance spectra of purified wild-type BM3h
derivatives following coexpression with ChuA and purification from cultures supplemented
with 30 μg/mL Mn(III), Fe(III), Co(III), or Zn(II) PPIX complexes. Inset: circular dichroism
spectra indicating the similarity of the secondary structures of ferric and manganic BM3h in
10 mM potassium phosphate (pH 7.4) and 100 mM (NH4)2SO4.
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Figure 2.
Longitudinal relaxivity and ligand responsiveness of Mn3+-substituted BM3h proteins. (A)
Nuclear magnetic relaxation dispersion profile of wild-type (WT) Mn-BM3h (●) vs native
ferric BM3h (○). Points at 200 MHz were measured in a 4.7 T MRI scanner, and the
remaining points were obtained using a variable-field relaxometer. (B) Diverse
combinations of molar T1 relaxivity (r1) at 4.7 T and half-maximal 10 min denaturation
temperature (T50) were observed among manganic BM3h variants formed from WT BM3h,
the dopamine sensor B7, and thermostable chimeric BM3h homologues (C1607, C1611,
C1625, C1634, and C1644). (C) Normalized optical absorbance changes of 5 μM Mn-C1634
in PBS as a function of arachidonic acid (AA) concentration. Error bars denote standard
errors of the mean (n = 4). Data points were computed from difference spectra (inset; higher
AA concentrations correspond to darker lines) by subtracting absorbance changes observed
at λ = 380 and 430 nm (arrowheads). (D) Representative longitudinal molar relaxivities (r1)
observed at 4.7 T during an AA titration into 54 μM Mn-C1634 in PBS. The inset shows
corresponding spin-echo image data with TR/TE = 1221/10 ms. Lines in C and D were
obtained by fitting the data to a two-component binding model.
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